Localization of G-protein-coupled receptors in health and disease

Trends in Pharmacological Sciences

Volumn 21, Issue 8, 2000, Pages 304-308

  Edwards, Stephen W ^a   Tan, Christopher M ^b   Limbird, Lee E ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; TRANSMEMBRANE CONDUCTANCE REGULATOR;

CYSTIC FIBROSIS; HUMAN; NEPHROGENIC DIABETES INSIPIDUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR OCCUPANCY; REGULATORY MECHANISM; RETINITIS PIGMENTOSA; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL MEMBRANE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DIABETES INSIPIDUS; GTP-BINDING PROTEINS; HUMANS; HYPERCHOLESTEROLEMIA; RECEPTORS, CELL SURFACE; RECEPTORS, LDL; RETINITIS PIGMENTOSA;

EID: 0034255332     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(00)01513-3     Document Type: Review

References (46)

1. Hamm, H.E. (1998) The many faces of G protein signaling. J. Biol. Chem. 273, 669-672
2. Bunemann, M. et al. (1999) Desensitization of G-protein-coupled receptors in the cardiovascular system. Annu. Rev. Physiol. 61, 169-192
3. Pitcher, J.A. et al. (1998) G protein-coupled receptor kinases. Annu. Rev. Biochem. 67, 653-692
4. Hobbs, H.H. et al. (1990) The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. Annu. Rev. Genet. 24, 133-170
5. Patel, D.D. et al. (1998) Analysis of two duplications of the LDL receptor gene affecting intracellular transport, catabolism, and surface binding of the LDL receptor. J. Lipid Res. 39, 1466-1475
6. Welsh, M.J. and Smith, A.E. (1993) Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73, 1251-1254
7. Denning, G.M. et al. (1992) Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358, 761-764
8. van Soest, S. et al. (1999) Retinitis pigmentosa: defined from a molecular point of view. Surv. Ophthalmol. 43, 321-334
9. Dryja, T.P. and Li, T. (1995) Molecular genetics of retinitis pigmentosa. Hum. Mol. Genet. 4, 1739-1743
10. Sung, C.H. et al. (1993) Rhodopsin mutations responsible for autosomal dominant retinitis pigmentosa. Clustering of functional classes along the polypeptide chain. J. Biol. Chem. 268, 26645-26649
11. Sung, C.H. et al. (1994) A rhodopsin gene mutation responsible for autosomal dominant retinitis pigmentosa results in a protein that is defective in localization to the photoreceptor outer segment. J. Neurosci. 14, 5818-5833
12. Li, T. et al. (1996) Transgenic mice carrying the dominant rhodopsin mutation P347S: evidence for defective vectorial transport of rhodopsin to the outer segments. Proc. Natl. Acad. Sci. U. S. A. 93, 14176-14181
13. Deretic, D. et al. (1996) Cytoplasmic domain of rhodopsin is essential for post-Golgi vesicle formation in a retinal cell-free system. J. Biol. Chem. 271, 2279-2286
14. Oksche, A. and Rosenthal, W. (1998) The molecular basis of nephrogenic diabetes insipidus. J. Mol. Med. 76, 326-337
15. Tsukaguchi, H. et al. (1995) Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus. J. Clin. Invest. 96, 2043-2050
16. 2 vasopressin receptor mutants. J. Clin. Invest. 105, 887-895
17. 2 receptor gene mutations. Mol. Cell. Endocrinol. 124, 43-50
18. 2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function. Mol. Pharmacol. 50, 820-828
19. 2 receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide. EMBO J. 15, 1283-1291
20. 2 receptors by adenovirus-mediated gene transfer. Molecular basis and clinical implication. J. Clin. Invest. 100, 1547-1556
21. 2 vasopressin receptor is temperature sensitive. FASEB J. 14, A1424, 645
22. Neubig, R.R. (1994) Membrane organization in G-protein mechanisms. FASEB J. 8, 939-946
23. De Lean, A. et al. (1980) A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J. Biol. Chem. 255, 7108-7117
24. 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry. Mol. Pharmacol. 28, 475-486
25. 2 adenosine receptors. II. A restricted collision-coupling model of receptor-effector interaction. Mol. Pharmacol. 39, 524-530
26. 2-adrenergic receptor subtypes achieve basolateral localization in Madin-Darby canine kidney II cells via different targeting mechanisms. J. Biol. Chem. 271, 5017-5024
27. 2A-adrenergic receptor is targeted directly to the basolateral membrane domain of Madin-Darby canine kidney cells independent of coupling to pertussis toxin-sensitive GTP-binding proteins. J. Biol. Chem. 268, 11340-11347
28. 2A-adrenergic receptor on the basolateral membrane of Madin-Darby canine kidney cells. J. Biol. Chem. 269, 16425-16433
29. Ikonen, E. and Simons, K. (1998) Protein and lipid sorting from the trans-Golgi network to the plasma membrane in polarized cells. Semin. Cell Dev. Biol. 9, 503-509
30. 2-adrenergic receptor subtypes in cells and tissues. Pharmacol. Ther. 84, 193-205
31. 1. J. Biol. Chem. 265, 1239-1242
32. Carlson, K.E. et al. (1986) Fractionation of the β subunit common to guanine nucleotide-binding regulatory proteins with the cytoskeleton. Mol. Pharmacol. 30, 463-468
33. Sarndahl, E. et al. (1993) Stimulus-induced dissociation of α subunits of heterotrimeric GTP-binding proteins from the cytoskeleton of human neutrophils. Proc. Natl. Acad. Sci. U. S. A. 90, 6552-6556
34. Klotz, K.N. et al. (1994) Regulatory interaction of N-formyl peptide chemoattractant receptors with the membrane skeleton in human neutrophils. J. Immunol. 152, 801-810
35. Zitzer, H. et al. (1999) Somatostatin receptor interacting protein defines a novel family of multidomain proteins present in human and rodent brain J. Biol. Chem. 274, 32997-33001
36. Jans, D.A. (1992) The mobile receptor hypothesis revisited: a mechanistic role for hormone receptor lateral mobility in signal transduction. Biochim. Biophys. Acta 1113, 271-276
37. De Diego, J.G. et al. (1991) The relationship of ligand receptor mobility to internalization of polypeptide hormones and growth factors. Endocrinology 128, 2136-2140
38. Johansson, B. et al. (1993) N-formyl peptide receptors in human neutrophils display distinct membrane distribution and lateral mobility when labeled with agonist and antagonist. J. Cell Biol. 121, 1281-1289
39. Rodbell, M. (1995) Nobel Lecture. Signal transduction: evolution of an idea. Biosci. Rep. 15, 117-133
40. Jahangeer, S. and Rodbell, M. (1993) The disaggregation theory of signal transduction revisited: further evidence that G proteins are multimeric and disaggregate to monomers when activated. Proc. Natl. Acad. Sci. U. S. A. 90, 8782-8786
41. 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET) Proc. Natl. Acad. Sci. U. S. A. 97, 3684-3689
42. Jordan, B.A. and Devi, L.A. (1999) G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399, 697-700
43. 2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J. Biol. Chem. 271, 16384-16392
44. Xiao, B. et al. (1998) Homer regulates the association of Group 1 metabotropic glutamate receptors with multivalent complexes of Homer-related, synaptic proteins. Neuron 21, 707-718
45. Smith, F.D. et al. (1999) Association of the D2 dopamine receptor third cytoplasmic loop with spinophilin, a protein phosphatase-1-interacting protein. J. Biol. Chem. 274, 19894-19900
46. 2-adrenergic receptors interact with spinophilin via their third intracellular loops. FASEB J. 14, A1317, 37